@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_head { this: np:hasAssertion dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_assertion; np:hasProvenance dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_provenance; np:hasPublicationInfo dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_publicationInfo; a np:Nanopublication . dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_assertion a np:Assertion . dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_provenance a np:Provenance . dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_publicationInfo a np:PublicationInfo . } dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_assertion { miriam-gene:6774 a ncit:C16612 . lld:C0024899 a ncit:C7057 . dgn-gda:DGNb5b11d8012fbfab5cfa655e04f442aec sio:SIO_000628 miriam-gene:6774, lld:C0024899; a sio:SIO_001121 . } dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_provenance { dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_assertion dcterms:description "[We show that (a) APcK110 inhibits proliferation of the mastocytosis cell line HMC1.2 and the SCF-responsive cell line OCI/AML3 in a dose-dependent manner; (b) APcK110 is a more potent inhibitor of OCI/AML3 proliferation than the clinically used Kit inhibitors imatinib and dasatinib and at least as potent as cytarabine; (c) APcK110 inhibits the phosphorylation of Kit, Stat3, Stat5, and Akt in a dose-dependent fashion, showing activity of APcK110 on Kit and its downstream signaling pathways; (d) APcK110 induces apoptosis by cleavage of caspase-3 and poly(ADP-ribose) polymerase; and (e) APcK110 inhibits proliferation of primary AML blasts in a clonogenic assay but does not affect proliferation of normal colony-forming cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:19383925; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP716387.RAjHdSA1N6VvJQ0Q5b1EW0tXSegBLU0Rv3UizxQtd8Aow130_publicationInfo { this: dcterms:created "2015-08-25T14:44:52+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }